IBDEI1LS ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,25974,1,4,0)
;;=4^Z91.120
;;^UTILITY(U,$J,358.3,25974,2)
;;=^5063612
;;^UTILITY(U,$J,358.3,25975,0)
;;=Z91.128^^92^1189^2
;;^UTILITY(U,$J,358.3,25975,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25975,1,3,0)
;;=3^Intentional Underdosing,Other Reasons
;;^UTILITY(U,$J,358.3,25975,1,4,0)
;;=4^Z91.128
;;^UTILITY(U,$J,358.3,25975,2)
;;=^5063613
;;^UTILITY(U,$J,358.3,25976,0)
;;=Z91.130^^92^1189^15
;;^UTILITY(U,$J,358.3,25976,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25976,1,3,0)
;;=3^Unintented Underdosing d/t Age-Related Disability
;;^UTILITY(U,$J,358.3,25976,1,4,0)
;;=4^Z91.130
;;^UTILITY(U,$J,358.3,25976,2)
;;=^5063614
;;^UTILITY(U,$J,358.3,25977,0)
;;=Z91.138^^92^1189^16
;;^UTILITY(U,$J,358.3,25977,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25977,1,3,0)
;;=3^Unintented Underdosing,Other Reasons
;;^UTILITY(U,$J,358.3,25977,1,4,0)
;;=4^Z91.138
;;^UTILITY(U,$J,358.3,25977,2)
;;=^5063615
;;^UTILITY(U,$J,358.3,25978,0)
;;=T38.3X6A^^92^1189^3
;;^UTILITY(U,$J,358.3,25978,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25978,1,3,0)
;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Init Encntr
;;^UTILITY(U,$J,358.3,25978,1,4,0)
;;=4^T38.3X6A
;;^UTILITY(U,$J,358.3,25978,2)
;;=^5049649
;;^UTILITY(U,$J,358.3,25979,0)
;;=T38.3X6S^^92^1189^4
;;^UTILITY(U,$J,358.3,25979,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25979,1,3,0)
;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
;;^UTILITY(U,$J,358.3,25979,1,4,0)
;;=4^T38.3X6S
;;^UTILITY(U,$J,358.3,25979,2)
;;=^5049651
;;^UTILITY(U,$J,358.3,25980,0)
;;=T38.3X6D^^92^1189^5
;;^UTILITY(U,$J,358.3,25980,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25980,1,3,0)
;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
;;^UTILITY(U,$J,358.3,25980,1,4,0)
;;=4^T38.3X6D
;;^UTILITY(U,$J,358.3,25980,2)
;;=^5049650
;;^UTILITY(U,$J,358.3,25981,0)
;;=T46.5X6A^^92^1189^9
;;^UTILITY(U,$J,358.3,25981,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25981,1,3,0)
;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
;;^UTILITY(U,$J,358.3,25981,1,4,0)
;;=4^T46.5X6A
;;^UTILITY(U,$J,358.3,25981,2)
;;=^5051353
;;^UTILITY(U,$J,358.3,25982,0)
;;=T46.5X6D^^92^1189^10
;;^UTILITY(U,$J,358.3,25982,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25982,1,3,0)
;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
;;^UTILITY(U,$J,358.3,25982,1,4,0)
;;=4^T46.5X6D
;;^UTILITY(U,$J,358.3,25982,2)
;;=^5051354
;;^UTILITY(U,$J,358.3,25983,0)
;;=T46.5X6S^^92^1189^11
;;^UTILITY(U,$J,358.3,25983,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25983,1,3,0)
;;=3^Underdosing of Antihypertensive Drugs,Sequela
;;^UTILITY(U,$J,358.3,25983,1,4,0)
;;=4^T46.5X6S
;;^UTILITY(U,$J,358.3,25983,2)
;;=^5051355
;;^UTILITY(U,$J,358.3,25984,0)
;;=T43.206A^^92^1189^6
;;^UTILITY(U,$J,358.3,25984,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25984,1,3,0)
;;=3^Underdosing of Antidepressants,Init Encntr
;;^UTILITY(U,$J,358.3,25984,1,4,0)
;;=4^T43.206A
;;^UTILITY(U,$J,358.3,25984,2)
;;=^5050543
;;^UTILITY(U,$J,358.3,25985,0)
;;=T43.206S^^92^1189^7
;;^UTILITY(U,$J,358.3,25985,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25985,1,3,0)
;;=3^Underdosing of Antidepressants,Sequela
;;^UTILITY(U,$J,358.3,25985,1,4,0)
;;=4^T43.206S
;;^UTILITY(U,$J,358.3,25985,2)
;;=^5050545
;;^UTILITY(U,$J,358.3,25986,0)
;;=T43.206D^^92^1189^8
;;^UTILITY(U,$J,358.3,25986,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1LS 3797 printed Sep 15, 2024@21:35:25 Page 2
IBDEI1LS ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,25974,1,4,0)
+2 ;;=4^Z91.120
+3 ;;^UTILITY(U,$J,358.3,25974,2)
+4 ;;=^5063612
+5 ;;^UTILITY(U,$J,358.3,25975,0)
+6 ;;=Z91.128^^92^1189^2
+7 ;;^UTILITY(U,$J,358.3,25975,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,25975,1,3,0)
+10 ;;=3^Intentional Underdosing,Other Reasons
+11 ;;^UTILITY(U,$J,358.3,25975,1,4,0)
+12 ;;=4^Z91.128
+13 ;;^UTILITY(U,$J,358.3,25975,2)
+14 ;;=^5063613
+15 ;;^UTILITY(U,$J,358.3,25976,0)
+16 ;;=Z91.130^^92^1189^15
+17 ;;^UTILITY(U,$J,358.3,25976,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,25976,1,3,0)
+20 ;;=3^Unintented Underdosing d/t Age-Related Disability
+21 ;;^UTILITY(U,$J,358.3,25976,1,4,0)
+22 ;;=4^Z91.130
+23 ;;^UTILITY(U,$J,358.3,25976,2)
+24 ;;=^5063614
+25 ;;^UTILITY(U,$J,358.3,25977,0)
+26 ;;=Z91.138^^92^1189^16
+27 ;;^UTILITY(U,$J,358.3,25977,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,25977,1,3,0)
+30 ;;=3^Unintented Underdosing,Other Reasons
+31 ;;^UTILITY(U,$J,358.3,25977,1,4,0)
+32 ;;=4^Z91.138
+33 ;;^UTILITY(U,$J,358.3,25977,2)
+34 ;;=^5063615
+35 ;;^UTILITY(U,$J,358.3,25978,0)
+36 ;;=T38.3X6A^^92^1189^3
+37 ;;^UTILITY(U,$J,358.3,25978,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,25978,1,3,0)
+40 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Init Encntr
+41 ;;^UTILITY(U,$J,358.3,25978,1,4,0)
+42 ;;=4^T38.3X6A
+43 ;;^UTILITY(U,$J,358.3,25978,2)
+44 ;;=^5049649
+45 ;;^UTILITY(U,$J,358.3,25979,0)
+46 ;;=T38.3X6S^^92^1189^4
+47 ;;^UTILITY(U,$J,358.3,25979,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,25979,1,3,0)
+50 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
+51 ;;^UTILITY(U,$J,358.3,25979,1,4,0)
+52 ;;=4^T38.3X6S
+53 ;;^UTILITY(U,$J,358.3,25979,2)
+54 ;;=^5049651
+55 ;;^UTILITY(U,$J,358.3,25980,0)
+56 ;;=T38.3X6D^^92^1189^5
+57 ;;^UTILITY(U,$J,358.3,25980,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,25980,1,3,0)
+60 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
+61 ;;^UTILITY(U,$J,358.3,25980,1,4,0)
+62 ;;=4^T38.3X6D
+63 ;;^UTILITY(U,$J,358.3,25980,2)
+64 ;;=^5049650
+65 ;;^UTILITY(U,$J,358.3,25981,0)
+66 ;;=T46.5X6A^^92^1189^9
+67 ;;^UTILITY(U,$J,358.3,25981,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,25981,1,3,0)
+70 ;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
+71 ;;^UTILITY(U,$J,358.3,25981,1,4,0)
+72 ;;=4^T46.5X6A
+73 ;;^UTILITY(U,$J,358.3,25981,2)
+74 ;;=^5051353
+75 ;;^UTILITY(U,$J,358.3,25982,0)
+76 ;;=T46.5X6D^^92^1189^10
+77 ;;^UTILITY(U,$J,358.3,25982,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,25982,1,3,0)
+80 ;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
+81 ;;^UTILITY(U,$J,358.3,25982,1,4,0)
+82 ;;=4^T46.5X6D
+83 ;;^UTILITY(U,$J,358.3,25982,2)
+84 ;;=^5051354
+85 ;;^UTILITY(U,$J,358.3,25983,0)
+86 ;;=T46.5X6S^^92^1189^11
+87 ;;^UTILITY(U,$J,358.3,25983,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,25983,1,3,0)
+90 ;;=3^Underdosing of Antihypertensive Drugs,Sequela
+91 ;;^UTILITY(U,$J,358.3,25983,1,4,0)
+92 ;;=4^T46.5X6S
+93 ;;^UTILITY(U,$J,358.3,25983,2)
+94 ;;=^5051355
+95 ;;^UTILITY(U,$J,358.3,25984,0)
+96 ;;=T43.206A^^92^1189^6
+97 ;;^UTILITY(U,$J,358.3,25984,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,25984,1,3,0)
+100 ;;=3^Underdosing of Antidepressants,Init Encntr
+101 ;;^UTILITY(U,$J,358.3,25984,1,4,0)
+102 ;;=4^T43.206A
+103 ;;^UTILITY(U,$J,358.3,25984,2)
+104 ;;=^5050543
+105 ;;^UTILITY(U,$J,358.3,25985,0)
+106 ;;=T43.206S^^92^1189^7
+107 ;;^UTILITY(U,$J,358.3,25985,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,25985,1,3,0)
+110 ;;=3^Underdosing of Antidepressants,Sequela
+111 ;;^UTILITY(U,$J,358.3,25985,1,4,0)
+112 ;;=4^T43.206S
+113 ;;^UTILITY(U,$J,358.3,25985,2)
+114 ;;=^5050545
+115 ;;^UTILITY(U,$J,358.3,25986,0)
+116 ;;=T43.206D^^92^1189^8
+117 ;;^UTILITY(U,$J,358.3,25986,1,0)
+118 ;;=^358.31IA^4^2
